Rein Piir

Rein Piir currently works at Piir & Partner AB, as Chairman & Chief Executive Officer from 2015, Trygga Pengar I Mobilen Sverige AB, as Director, Lesvensson Snickeri AB, as Director, IRLAB Therapeutics AB, as Independent Director from 2016, and L E Svensson Snickeri AB, as Director.
Mr. Piir also formerly worked at Hw Svenskt Reklamscreen AB, as Director, Medivir Personal AB, as Director, Cereno Scientific AB, as Director from 2021 to 2023, Medivir AB, as EVP-Corporate Affairs & Investor Relations from 2012 to 2015, Carnegie Investment Bank AB, as Head-Analysis, Alligator Bioscience AB, as Vice President-Investor Relations from 2016 to 2017, Oncopeptides AB, as Head-Investor Relations from 2016 to 2020, Camurus AB, as Vice President & Head-Investor Relations, Alecta AB, as Head-Strategy, and PricewaterhouseCoopers AB, as Auditor.
Mr. Piir received his graduate degree from the University of Uppsala.